Neurobiological Technologies INC /CA/
SEC CIK 918112 · NTII · last insider filing 2010-06-09
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Stuppin John B | Director | filed 2006 - 2009 |
| Cohen Abraham E | Director | filed 2006 - 2009 |
| Sofaer Abraham D | Director | filed 2006 - 2009 |
| Eliot Theodore | Director | filed 2006 - 2009 |
| Kasper F VAN | Director | filed 2006 - 2009 |
| Fletcher William A | Director · Acting Chief Executive Officer | filed 2007 - 2009 |
| Freiman Paul E | Director · President and CEO | filed 2006 - 2009 |
| Callaway Enoch | Director | filed 2006 - 2008 |
| Cape Ronald | Director | filed 2006 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wasiewski Warren W | Vice President, CMO | filed 2008 - 2008 |
| Loar Matthew M | VP and Chief Financial Officer | filed 2008 - 2008 |
| Levy David E | VP of Clinical Development | filed 2007 - 2008 |
| Carlson Craig W | VP and Chief Financial Officer | filed 2006 - 2007 |
| Petti Stephen J | VP of Product Development | filed 2006 - 2006 |
| Carr Lisa U MD PHD | Sr. Vice President | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.